IP Library Granted Patent US 11,905,543
Granted Patent B2
US 11,905,543 · App. 16/425,654 · Granted Feb 20, 2024

In vivo generation of water-soluble acetylated cannabinoid glycoside compounds in plant cell suspension cultures

Inventors: Richard T. Sayre (Los Alamos, NM); Elton Carvalho Gonçalves (Los Alamos, NM); Tawanda Zidenga (White Rock, NM); Stephanie Willette (Santa Fe, NM)
Assignee: TRAIT BIOSCEINCES, INC.
C12P7/22A61K9/0056A61K31/352A61K36/81C12P19/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,905,543
App. No.
16/425,654
Granted
Feb 20, 2024
Kind
B2
Abstract

The present invention includes systems, methods and compositions for the in vivo bioconversion of water-soluble acetylated cannabinoid glycosides in plant cell suspension cultures.

Claims (6)

1. An in vivo method for the generation of water-soluble cannabinoids, comprising the steps of:

(a) establishing a tobacco cell suspension culture;

(b) introducing a cannabinoid having at least one glycosylation site to said tobacco cell suspension culture, wherein said cannabinoid is selected from the group consisting of: cannabigerol (CBG), cannabigerolic acid (CBGA), cannabidiol (CBD), and cannabidiolic acid (CBDA);

(c) incubating said cannabinoid in said tobacco cell suspension culture, thereby glycosylating the cannabinoid; and

(d) isolating a cannabinoid glycoside from said tobacco cell suspension culture, wherein said cannabinoid glycoside is selected from the group consisting of CBG-glycoside, CBD-glycoside, CBGA-glycoside and CBDA-glycoside;

wherein said tobacco cell suspension culture is a Nicotiana tabacum cell suspension culture or a Nicotiana benthamiana cell suspension culture.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2021
From: GOTHAM GREEN ADMIN 1, LLC
To: TRAIT BIOSCIENCES INC., TRAIT NM INC., TRAIT BIOSCIENCES (CANADA) INC., AND TWIGG PHARMA LTD.
Reel/Frame 055705/0452 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2020
From: CARVALHO GONÇALVES, ELTON, DR.
To: TRAIT BIOSCEINCES, INC.
Reel/Frame 054626/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2020
From: ZIDENGA, TAWANDA, DR.
To: TRAIT BIOSCEINCES, INC.
Reel/Frame 054626/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2020
From: WILLETTE, STEPHANIE, DR.
To: TRAIT BIOSCIENCES, INC.
Reel/Frame 054626/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2020
From: SAYRE, RICHARD T., DR.
To: TRAIT BIOSCEINCES, INC.
Reel/Frame 054623/0738 →
SECURITY INTEREST Recorded Jun 26, 2020
From: TRAIT BIOSCIENCES INC.; TRAIT NM INC.; TRAIT BIOSCIENCES (CANADA) INC.; TWIGG PHARMA LTD.
To: GOTHAM GREEN ADMIN 1, LLC
Reel/Frame 053057/0852 →
Continuity (7)
Continuation In Part 16110954 · Aug 23, 2018
Continuation In Part PCTUS2018041710 · Jul 11, 2018
Continuation In Part PCTUS2018024409 · Mar 26, 2018
Provisional Application 62531123 · Jul 11, 2017
Provisional Application 62588662 · Nov 20, 2017
Provisional Application 62621166 · Jan 24, 2018
Related Publication 20190382807A1 · Dec 19, 2019